Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Moodys
Chinese Patent Office
Colorcon
Fuji
Daiichi Sankyo
US Department of Justice
Mallinckrodt
McKinsey
Julphar
Citi

Generated: August 21, 2017

DrugPatentWatch Database Preview

CEFOXITIN AND DEXTROSE IN DUPLEX CONTAINER Drug Profile

« Back to Dashboard

What is the patent landscape for Cefoxitin And Dextrose In Duplex Container, and when can generic versions of Cefoxitin And Dextrose In Duplex Container launch?

Cefoxitin And Dextrose In Duplex Container is a drug marketed by B Braun and is included in one NDA.

The generic ingredient in CEFOXITIN AND DEXTROSE IN DUPLEX CONTAINER is cefoxitin sodium. There are eight drug master file entries for this compound. Nine suppliers are listed for this compound. Additional details are available on the cefoxitin sodium profile page.

Summary for Tradename: CEFOXITIN AND DEXTROSE IN DUPLEX CONTAINER

Patents:0
Applicants:1
NDAs:1
Suppliers / Packagers: see list1
Bulk Api Vendors: see list35
Clinical Trials: see list105,730
Patent Applications: see list802
Formulation / Manufacturing:see details
Drug Prices:see details
DailyMed Link:CEFOXITIN AND DEXTROSE IN DUPLEX CONTAINER at DailyMed

Pharmacology for Tradename: CEFOXITIN AND DEXTROSE IN DUPLEX CONTAINER

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
B Braun
CEFOXITIN AND DEXTROSE IN DUPLEX CONTAINER
cefoxitin sodium
INJECTABLE;INJECTION065214-001Mar 10, 2006APRXYesYes► Subscribe► Subscribe► Subscribe
B Braun
CEFOXITIN AND DEXTROSE IN DUPLEX CONTAINER
cefoxitin sodium
INJECTABLE;INJECTION065214-002Mar 10, 2006APRXYesYes► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Merck
Dow
AstraZeneca
Mallinckrodt
Federal Trade Commission
US Department of Justice
Farmers Insurance
Julphar
Covington
Boehringer Ingelheim

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot